News
Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...
Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care radiotherapy improves event-free survival in patients with resectable, locally ...
In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how clinical teams can boost participant retention in lengthy or complex trials through strategies like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results